BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+32.49%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$588M
AUM Growth
+$588M
(+18%)
Cap. Flow
-$173M
Cap. Flow
% of AUM
-29.44%
Top 10 Holdings %
Top 10 Hldgs %
70.6%
Holding
33
New
4
Increased
8
Reduced
8
Closed
3
Top Buys
| 1 |
AnaptysBio
ANAB
|
$48.2M |
| 2 |
CytomX Therapeutics
CTMX
|
$21.6M |
| 3 |
BLRX
BioLineRX
BLRX
|
$16.8M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$13.5M |
| 5 |
Xoma
XOMA
|
$8.53M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$46.1M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$19.9M |
| 3 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$17.6M |
| 4 |
Esperion Therapeutics
ESPR
|
$8.92M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$8.5M |
Sector Composition
| 1 | Healthcare | 75.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANTH
26
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $3.43M | 0.58% |
8,052,073
+7,989,781
| +12,826% | +$3.4M |
|
|
OREX
27
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.53M | 0.43% |
734,976
| – | – |
|
28
Cassava Sciences
SAVA
$107M
| $2.04M | 0.35% |
2,278,552
| – | – |
|
|
RGLS
29
DELISTED
Regulus Therapeutics
RGLS
| $1.03M | 0.17% |
+623,000
| New | +$1.03M |
|
|
CLCD
30
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| – | – |
-484,335
| Closed | -$17.6M |
|
|
KDNY
31
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-745,886
| Closed | -$8.5M |
|
|
32
Esperion Therapeutics
ESPR
$490M
| – | – |
-712,770
| Closed | -$8.92M |
|